TownSquare Capital’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

TownSquare Capital’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-533	Closed	-$50K	–	645
2021 Q1	$50K	Buy	+533	New	+$54K	﹤0.01%	560
2020 Q3	–	Sell	-333	Closed	-$38K	–	458
2020 Q2	$38K	Buy	+333	New	+$18.3K	﹤0.01%	407

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

TownSquare Capital's VBIV Position: Q2 2021 in Review

TownSquare Capital sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2021, closing a stake of 533 shares — an estimated $50K sold.

TownSquare Capital first reported a position in VBIV in Q2 2020 and held it in 2 quarters. The position peaked at $50K in Q1 2021. 134 funds tracked by Wall St. Rank hold VBIV as of Q2 2021.

TownSquare Capital reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2021 after selling out during the quarter.
TownSquare Capital sold 533 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2021, an estimated $50K.
TownSquare Capital first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and held it in 2 quarters.
TownSquare Capital's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $50K in Q1 2021.
134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2021.

Based on TownSquare Capital's 13F filing for Q2 2021, filed 16 Aug 2021.